Kumulus Partners acted as M&A and Debt Adviser to Naxicap Partners in the acquisition of Ceres Pharma.
Ceres Pharma, a Belgian based pharmaceutical company, grew substantially over the last years, both organically and through acquisitions, resulting in a growing number of own brands and a significant increase in geographical reach, namely in Central and Eastern Europe.
Kumulus provided buy side M&A advisory services to Naxicap. Kumulus also arranged the debt acquisition facility in this deal.
